Literature DB >> 31430394

Advancing the Science of Deprescribing: A Novel Comprehensive Conceptual Framework.

Amy Linsky1, Walid F Gellad2, Jeffrey A Linder3, Mark W Friedberg4.   

Abstract

Polypharmacy is common in older adults and associated with inappropriate medication use, adverse drug events, medication nonadherence, higher costs, and increased mortality compared with those without polypharmacy. Deprescribing, the clinically supervised process of stopping or reducing the dose of medications when they cause harm or no longer provide benefit, may improve outcomes. Although potentially beneficial, clinicians struggle to overcome structural, organizational, technological, and cognitive barriers to deprescribing, limiting its use in clinical practice. Deprescribing science would benefit from a unifying conceptual framework to prioritize research. Current deprescribing conceptual frameworks have made important contributions to the field but often with a focus on specific medication classes or aspects of deprescribing. To further this relatively nascent field, we developed a broader deprescribing conceptual framework that builds on prior frameworks and includes patient, prescriber, and system influences; the process of deprescribing; outcomes; and dissemination. Patient factors include patients' biology, experience, values, and preferences. Prescriber factors include rational (eg, based on explicit knowledge) and nonrational (eg, behavioral tendencies, biases, and heuristics) decision making. System factors include resources, incentives, goals, and culture that contribute to deprescribing. The framework separates the deprescribing decision from the deprescribing process. The framework captures the results of deprescribing by examining changes in clinical structures, performance processes, patient experience, health outcomes, and cost. Through testing and refinement, this novel, more comprehensive conceptual framework has the potential to advance deprescribing research by organizing the existing evidence, identifying evidence gaps, and categorizing deprescribing interventions and the settings in which they are applied. J Am Geriatr Soc 67:2018-2022, 2019.
© 2019 The American Geriatrics Society.

Entities:  

Keywords:  behavioral economics; clinical decision making; health services for older adults; implementation science; polypharmacy

Mesh:

Year:  2019        PMID: 31430394      PMCID: PMC6800794          DOI: 10.1111/jgs.16136

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  35 in total

1.  Asking for 'rules of thumb': a way to discover tacit knowledge in general practice.

Authors:  Malin André; L Borgquist; M Foldevi; S Mölstad
Journal:  Fam Pract       Date:  2002-12       Impact factor: 2.267

2.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

3.  Deprescribing: what is it and what does the evidence tell us?

Authors:  Wade Thompson; Barbara Farrell
Journal:  Can J Hosp Pharm       Date:  2013-05

Review 4.  Review of structured guides for deprescribing.

Authors:  Ian Scott; Kristen Anderson; Christopher Freeman
Journal:  Eur J Hosp Pharm       Date:  2017-01

5.  Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial.

Authors:  Daniella Meeker; Jeffrey A Linder; Craig R Fox; Mark W Friedberg; Stephen D Persell; Noah J Goldstein; Tara K Knight; Joel W Hay; Jason N Doctor
Journal:  JAMA       Date:  2016-02-09       Impact factor: 56.272

6.  Financial toxicity, Part I: a new name for a growing problem.

Authors:  S Yousuf Zafar; Amy P Abernethy
Journal:  Oncology (Williston Park)       Date:  2013-02       Impact factor: 2.990

7.  Deprescribing guidelines: An international symposium on development, implementation, research and health professional education.

Authors:  Barbara Farrell; James Conklin; Lisa Dolovich; Hannah Irving; Malcolm Maclure; Lisa McCarthy; Frank Moriarty; Kevin Pottie; Lalitha Raman-Wilms; Emily Reeve; Wade Thompson
Journal:  Res Social Adm Pharm       Date:  2018-09-18

8.  Deprescribing: Future directions for research.

Authors:  Wade Thompson; Emily Reeve; Frank Moriarty; Malcolm Maclure; Justin Turner; Michael A Steinman; James Conklin; Lisa Dolovich; Lisa McCarthy; Barbara Farrell
Journal:  Res Social Adm Pharm       Date:  2018-09-18

9.  Deciding when to stop: towards evidence-based deprescribing of drugs in older populations.

Authors:  Ian A Scott; Leonard C Gray; Jennifer H Martin; Peter I Pillans; Charles A Mitchell
Journal:  Evid Based Med       Date:  2012-11-07

10.  Supporting medication discontinuation: provider preferences for interventions to facilitate deprescribing.

Authors:  Amy Linsky; Mark Meterko; Kelly Stolzmann; Steven R Simon
Journal:  BMC Health Serv Res       Date:  2017-06-28       Impact factor: 2.655

View more
  14 in total

Review 1.  Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis.

Authors:  Hanna E Bloomfield; Nancy Greer; Amy M Linsky; Jennifer Bolduc; Todd Naidl; Orly Vardeny; Roderick MacDonald; Lauren McKenzie; Timothy J Wilt
Journal:  J Gen Intern Med       Date:  2020-08-20       Impact factor: 5.128

Review 2.  A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review.

Authors:  Mouna Sawan; Emily Reeve; Justin Turner; Adam Todd; Michael A Steinman; Mirko Petrovic; Danijela Gnjidic
Journal:  Expert Rev Clin Pharmacol       Date:  2020-02-27       Impact factor: 5.045

Review 3.  N-of-1 trials to facilitate evidence-based deprescribing: Rationale and case study.

Authors:  Parag Goyal; Monika M Safford; Sarah N Hilmer; Michael A Steinman; Daniel D Matlock; Mathew S Maurer; Mark S Lachs; Ian M Kronish
Journal:  Br J Clin Pharmacol       Date:  2022-07-13       Impact factor: 3.716

Review 4.  Less is More: Deprescribing Medications in Older Adults with Kidney Disease: A Review.

Authors:  Dinushika Mohottige; Harold J Manley; Rasheeda K Hall
Journal:  Kidney360       Date:  2021-07-09

5.  Older Patient and Caregiver Perspectives on Medication Value and Deprescribing: A Qualitative Study.

Authors:  Aimee N Pickering; Megan E Hamm; Alicia Dawdani; Joseph T Hanlon; Carolyn T Thorpe; Walid F Gellad; Thomas R Radomski
Journal:  J Am Geriatr Soc       Date:  2020-02-17       Impact factor: 5.562

6.  Implementation of a Behavioral Economics Electronic Health Record (BE-EHR) Module to Reduce Overtreatment of Diabetes in Older Adults.

Authors:  Hayley M Belli; Sara K Chokshi; Roshini Hegde; Andrea B Troxel; Saul Blecker; Paul A Testa; Judd Anderman; Christina Wong; Devin M Mann
Journal:  J Gen Intern Med       Date:  2020-09-03       Impact factor: 5.128

7.  Prescriber perspectives on low-value prescribing: A qualitative study.

Authors:  Eric L Walter; Alicia Dawdani; Alison Decker; Megan E Hamm; Aimee N Pickering; Joseph T Hanlon; Carolyn T Thorpe; Mark S Roberts; Michael J Fine; Walid F Gellad; Thomas R Radomski
Journal:  J Am Geriatr Soc       Date:  2021-03-12       Impact factor: 7.538

8.  Integration of patient and clinician narratives into systematic reviews: An applied proof of concept.

Authors:  Vivian Christensen; Khaya Clark; Stephanie Tallett; Emily A Kenyon; Steven K Dobscha
Journal:  J Clin Transl Sci       Date:  2021-01-19

9.  Exploring Patients' Attitudes Toward Deprescribing and Their Perception of Pharmacist Involvement in a European Country: A Cross-Sectional Study.

Authors:  Iva Bužančić; Patricia Dragović; Tajana Iva Pejaković; Luka Markulin; Maja Ortner-Hadžiabdić
Journal:  Patient Prefer Adherence       Date:  2021-09-23       Impact factor: 2.711

10.  Primary care physicians' approaches to low-value prescribing in older adults: a qualitative study.

Authors:  Aimee N Pickering; Eric L Walter; Alicia Dawdani; Alison Decker; Megan E Hamm; Walid F Gellad; Thomas R Radomski
Journal:  BMC Geriatr       Date:  2022-02-24       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.